These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26562037)

  • 41. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
    Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
    Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Optimizing the clinical value of polyreactive autoantibodies to double-stranded DNA].
    Haberhauer G; Chlud K; Isovits D
    Z Gesamte Inn Med; 1989 Nov; 44(21):652-4. PubMed ID: 2692314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current status and problems associated with antinuclear antibody analysis by indirect fluorescent antibody method].
    Miyawaki S
    Nihon Rinsho Meneki Gakkai Kaishi; 1998 Feb; 21(1):1-10. PubMed ID: 10068254
    [No Abstract]   [Full Text] [Related]  

  • 44. [Significance of antinuclear antibodies in rheumatology].
    Ciobanu V; Boloşiu HD
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):97-111. PubMed ID: 2875509
    [No Abstract]   [Full Text] [Related]  

  • 45. Using the antinuclear antibody test to diagnose rheumatic diseases: when does a positive test warrant further investigation?
    Volkmann ER; Taylor M; Ben-Artzi A
    South Med J; 2012 Feb; 105(2):100-4. PubMed ID: 22267099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnostic value of antinuclear antibodies with special reference to the immunofluorescent speckled pattern].
    Anger RD
    Z Hautkr; 1986 Nov; 61(21):1515-23. PubMed ID: 2433842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EUROPattern Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics.
    Krause C; Ens K; Fechner K; Voigt J; Fraune J; Rohwäder E; Hahn M; Danckwardt M; Feirer C; Barth E; Martinetz T; Stöcker W
    Lupus; 2015 Apr; 24(4-5):516-29. PubMed ID: 25801895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enzyme immunoassays for antinuclear antibodies.
    Carey JL
    Clin Lab Med; 1997 Sep; 17(3):355-65. PubMed ID: 9316763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Staining pattern classification of antinuclear autoantibodies based on block segmentation in indirect immunofluorescence images.
    Li J; Tseng KK; Hsieh ZY; Yang CW; Huang HN
    PLoS One; 2014; 9(12):e113132. PubMed ID: 25474260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Harmonization of autoimmune diagnostics with antinuclear antibody testing algorithm: approach of appropriateness and clinical relevance.
    Melegari A; Bonaguri C
    Isr Med Assoc J; 2014 Oct; 16(10):640-2. PubMed ID: 25438456
    [No Abstract]   [Full Text] [Related]  

  • 52. [ANF-associated diseases ( lecture)].
    Ivanova SM; Speranskiĭ AI
    Klin Lab Diagn; 2003 Oct; (10):23-34. PubMed ID: 14663880
    [No Abstract]   [Full Text] [Related]  

  • 53. International Consensus on Antinuclear Antibody Patterns: defining negative results and reporting unidentified patterns.
    Herold M; Klotz W; Andrade LEC; Conrad K; de Melo Cruvinel W; Damoiseaux J; Fritzler MJ; von Muhlen CA; Satoh M; Chan EKL
    Clin Chem Lab Med; 2018 Sep; 56(10):1799-1802. PubMed ID: 29634478
    [No Abstract]   [Full Text] [Related]  

  • 54. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs.
    Sinclair D; Saas M; Williams D; Hart M; Goswami R
    Clin Lab; 2007; 53(3-4):183-91. PubMed ID: 17447656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical significance of autoantibodies to the pericentromeric heterochromatin protein 1a protein.
    Coppo P; Henry-Dessailly I; Rochette J; Lok C; Buendia B; Lassoued K
    Eur J Intern Med; 2013 Dec; 24(8):868-71. PubMed ID: 24184038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel cost effective algorithm for antinuclear antibody (ANA) testing in an outpatient setting.
    Barak M; Rozenberg O; Grinberg M; Reginashvili D; Kishinewsky M; Henig C; Froom P
    Clin Chem Lab Med; 2013 Jul; 51(7):e163-5. PubMed ID: 23045381
    [No Abstract]   [Full Text] [Related]  

  • 57. Antinuclear antibody and rheumatoid factor estimations in the diagnosis of rheumatic diseases in northern India.
    Malaviya AN; Banerjee S; Misra RN; Kaul R; Bhuyan UN
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):232-6. PubMed ID: 6335834
    [No Abstract]   [Full Text] [Related]  

  • 58. Are we at a stage to predict autoimmune rheumatic diseases?
    Bizzaro N; Tozzoli R; Shoenfeld Y
    Arthritis Rheum; 2007 Jun; 56(6):1736-44. PubMed ID: 17530702
    [No Abstract]   [Full Text] [Related]  

  • 59. Detection of antinuclear antibodies by the Inno-Lia ANA update test in canine systemic rheumatic disease.
    Hansson-Hamlin H; Rönnelid J
    Vet Clin Pathol; 2010 Jun; 39(2):215-20. PubMed ID: 19886972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnostic contribution of indirect immunofluorescence].
    Pretty HM
    Union Med Can; 1971 Nov; 100(11):2209-12. PubMed ID: 4948620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.